Advanced Search

Show simple item record

dc.contributor.authorGünal-Köroğlu, Deniz
dc.contributor.authorCatalkaya, Gizem
dc.contributor.authorYusufoğlu, Büşra
dc.contributor.authorKezer, Gizem
dc.contributor.authorEsatbeyoglu, Tuba
dc.contributor.authorAbd El-Aty A.M.
dc.contributor.authorCapanoglu, Esra
dc.date.accessioned2024-10-24T07:13:13Z
dc.date.available2024-10-24T07:13:13Z
dc.date.issued2024en_US
dc.identifier.citationGünal‐Köroğlu, D., Catalkaya, G., Yusufoğlu, B., Kezer, G., Esatbeyoglu, T., Abd El‐Aty, A. M., & Capanoglu, E. (2024). Quercetin: Potential antidiabetic effects through enzyme inhibition and starch digestibility. Food Safety and Health.en_US
dc.identifier.issn28351096
dc.identifier.urihttps://doi.org/10.1002/fsh3.12066
dc.identifier.urihttps://hdl.handle.net/20.500.12513/6957
dc.description.abstractDiabetes mellitus involves high blood sugar levels due to insufficient insulin action. Furthermore, enzymes such as α-amylase and α-glucosidase break down carbohydrates into glucose, leading to postprandial hyperglycemia. Flavonoids, particularly quercetin, inhibit these enzymes, slowing carbohydrate digestion and reducing glucose absorption. Quercetin has significant hypoglycemic effects with inhibitory concentration (IC50) values comparable to acarbose, a standard inhibitor, suggesting its potential as a natural alternative for diabetes management. In silico models, including molecular docking, molecular dynamics (MD) simulations, and quantitative structure-activity relationship (QSAR) approaches, help researchers understand the molecular interactions of therapeutic agents. These techniques identify potential inhibitors, determine enzyme-inhibitor structures, and calculate binding energies, correlating findings with in vitro or in vivo data. Molecular docking predicts molecular orientations, MD simulations offer insights into enzyme–inhibitor dynamics, and QSAR models predict inhibitory potential based on structural properties. Studies have shown that quercetin effectively inhibits α-glucosidase and α-amylase by forming hydrogen bonds with specific amino acid residues. Quercetin interacts with starches and reduces their digestibility, increases the formation of resistant starch, lowers the glycemic index, and inhibits digestive enzymes. Studies show that the effects of quercetin on starch digestion vary with concentration and type of starch, and its incorporation into foods such as bakery products, pasta, etc. can significantly decrease starch hydrolysis. The incorporation of quercetin into starch matrices may aid in the development of functional foods aimed at improving glycemic control. © 2024 The Author(s). Food Safety and Health published by John Wiley & Sons Australia, Ltd on behalf of International Association of Dietetic Nutrition and Safety.en_US
dc.language.isoengen_US
dc.publisherJohn Wiley and Sons Incen_US
dc.relation.isversionof10.1002/fsh3.12066en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectdigestionen_US
dc.subjectglycemic indexen_US
dc.subjectmolecular dockingen_US
dc.subjectresistant starchen_US
dc.subjectα-amylaseen_US
dc.subjectα-glucosidaseen_US
dc.titleQuercetin: Potential antidiabetic effects through enzyme inhibition and starch digestibilityen_US
dc.typeotheren_US
dc.relation.journalFood Safety and Healthen_US
dc.contributor.departmentZiraat Fakültesien_US
dc.contributor.authorIDGizem Kezer / 0000-0003-1530-3664en_US
dc.relation.publicationcategoryDiğeren_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record